Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: a randomised double-blind placebo-controlled clinical trial

References

• Adab Z, Eghtesadi S, Vafa M, Heydari I, Shojaei A, Haqqani H, Khorraminia N. 2013. Effect of turmeric on body measurement indices, glycemic condition, and lipid profile in hyperlipidemic patients with type 2 diabetes. Iran J Nutr Sci Food Technol. 8(3):217–227.
   Google Scholar
• Adibian M, Hodaei H, Nikpayam O, Sohrab G, Hekmatdoost A, Hedayati M. 2019. The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Phytother Res. 33(5):1374–1383.
   PubMed Web of Science ®Google Scholar
• Araújo MFM, Veras VS, Freitas RWJF, Paula ML, Araújo TM, Uchôa LRA, Gaspar MWG, Cunha MCSO, Serra MAAO, Carvalho CML, et al. 2017. The effect of flour from the rind of the yellow passion fruit on glycemic control of people with diabetes mellitus type 2: a randomized clinical trial. J Diabetes Metab Disord. 16:18.
   PubMed Web of Science ®Google Scholar
• Arivazhagan A, Krishna S, Yadav S, Shah HR, Kumar P, Ambasta RK. 2015. Synergy of bone marrow transplantation and curcumin ensue protective effects at early onset of diabetes in mice. J Diabetes. 7(4):473–484.
   PubMed Web of Science ®Google Scholar
• Brasil. 2017. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde. Vigitel Brasil 2016: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Brasília: Ministério da Saúde.
   Google Scholar
• Brazilian Diabetes Society (BDS). 2017. Diretrizes da Sociedade Brasileira de Diabetes: 2017–2018. São Paulo: Editora Clannad.
   Google Scholar
• Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. 2014. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem. 25(2):144–150.
   PubMed Web of Science ®Google Scholar
• Escosteguy CC. 1999. Methodological and statistical topics in randomized controlled clinical trials. Arq Bras Cardiol. 72(2):139–148.
   PubMedGoogle Scholar
• Hashemzaei M, Heravi RE, Rezaee R, Roohbakhsh A, Karimi G. 2017. Regulation of autophagy by some natural products as a potential therapeutic strategy for cardiovascular disorders. Eur J Pharmacol. 802:44–51.
   PubMed Web of Science ®Google Scholar
• Hodaei H, Adibian M, Nikpayam O, Hedayati M, Sohrab G. 2019. The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial. Diabetol Metab Syndr. 11(1):41.
   PubMedGoogle Scholar
• International Diabetes Federation (IDF). 2019. Diabetes atlas. 9th ed. Brussels, Belgium: International Diabetes Federation.
   Google Scholar
• Jiang S, Han J, Li T, Xin Z, Ma Z, Di W, Hu W, Gong B, Di S, Wang D, et al. 2017. Curcumin as a potential protective compound against cardiac diseases. Pharmacol Res. 119:373–383.
   PubMed Web of Science ®Google Scholar
• Kotha RR, Luthria DL. 2019. Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules. 24(16):2930.
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. 2017. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 174(11):1325–1348.
   PubMed Web of Science ®Google Scholar
• Nabavi SF, Thiagarajan R, Rastrelli L, Daglia M, Sobarzo-Sánchez E, Alinezhad H, Nabavi SM. 2015. Curcumin: a natural product for diabetes and its complications. Curr Top Med Chem. 15(23):2445–2455.
   PubMed Web of Science ®Google Scholar
• Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, Ghayour-Mobarhan M, Ferns GA. 2013. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother Res. 27(3):374–379.
   PubMed Web of Science ®Google Scholar
• Na LX, Li Y, Pan HZ, Zhou XL, Sun DJ, Meng M, Li XX, Sun CH. 2013. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol Nutr Food Res. 57(9):1569–1577.
   PubMed Web of Science ®Google Scholar
• Neerati P, Devde R, Gangi AK. 2014. Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus. Phytother Res. 28(12):1796–1800.
   PubMed Web of Science ®Google Scholar
• Panahi H, Khalili N, Sahebi E, Namazi S, Reiner Ž, Majeed M, Sahebkar A. 2017. Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial. Complement Ther Med. 33:1–5.
   PubMed Web of Science ®Google Scholar
• Panahi Y, Khalili N, Sahebi E, Namazi S, Simental-Mendía LE, Majeed M, Sahebkar A. 2018. Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial. Drug Res (Stuttg). 68(7):403–409.
   PubMed Web of Science ®Google Scholar
• Parhofer KG. 2015. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia. Diabetes Metab J. 39(5):353–362.
   PubMed Web of Science ®Google Scholar
• Pivari F, Mingione A, Brasacchio C, Soldati L. 2019. Curcumin and type 2 diabetes mellitus: prevention and treatment. Nutrients. 11(8):1837.
   Web of Science ®Google Scholar
• Poolsup N, Suksomboon N, Kurnianta PDM, Deawjaroen K. 2019. Effects of curcumin on glycemic control and lipid profile in prediabetes and type 2 diabetes mellitus: a systematic review and meta-analysis. PLoS One. 14(4):e0233919.
   Web of Science ®Google Scholar
• Qin S, Huang L, Gong J, Shen S, Huang J, Ren H, Hu H. 2017. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutr J. 16(1):68.
   PubMed Web of Science ®Google Scholar
• Scholze AFA. 2014. Biodisponibilidade da curcumina. Rev Bras Nutr Clin Func. 14(60):20–24.
   Google Scholar
• Simental-Mendía LE, Pirro M, Gotto AM, Banach M, Atkin SL, Majeed M, Sahebkar A. 2019. Lipid-modifying activity of curcuminoids: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 59(7):1178–1187.
   PubMed Web of Science ®Google Scholar
• Usharani P, Mateen AA, Naidu MUR, Raju YSN, Chandra N. 2008. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D. 9(4):243–250.
   PubMed Web of Science ®Google Scholar
• Vasques ACJ, Rosado L, Alfenas RCG, Geloneze B. 2008. Critical analysis on the use of the homeostasis model assessment (HOMA) indexes in the evaluation of the insulin resistance and the pancreatic beta cells functional capacity. Arq Bras Endocrinol Metabol. 52(1):32–39.
   PubMedGoogle Scholar
• Yekollu SK, Thomas R, O'Sullivan B. 2011. Targeting curcusomes to inflammatory dendritic cells inhibits NF-κB and improves insulin resistance in obese mice. Diabetes. 60(11):2928–2938.
   PubMed Web of Science ®Google Scholar